Zeltiq Aesthetics

Innovator of CoolSculpting, a non-invasive procedure for reducing fat

Zeltiq (NASDAQ: ZLTQ) is a medical device company focused on developing and commercializing CoolSculpting, a pioneering non-invasive procedure for body contouring and fat reduction. CoolSculpting uses controlled cooling (cryolipolysis) to target and kill fat cells, and there have been over 1.5 million CoolSculpting treatments performed worldwide. Zeltiq completed its IPO on NASDAQ in 2011.

Status

IPO in 2011 (NASDAQ: ZLTQ)

Year of Investment

2005

Strategy

Other

Location

Pleasanton, California